Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 12.63B | 12.49B | 12.21B | 12.37B | 11.79B |
Gross Profit | 10.69B | 5.08B | 4.91B | 5.08B | 4.42B |
EBITDA | 1.07B | 1.54B | 1.74B | 1.93B | 2.02B |
Net Income | -516.00M | -133.00M | 46.00M | 230.00M | 511.00M |
Balance Sheet | |||||
Total Assets | 14.05B | 14.46B | 14.67B | 15.22B | 16.01B |
Cash, Cash Equivalents and Short-Term Investments | 37.00M | 38.00M | 118.00M | 507.00M | 1.68B |
Total Debt | 12.10B | 12.17B | 12.39B | 12.82B | 12.88B |
Total Liabilities | 15.37B | 15.28B | 15.40B | 16.03B | 17.06B |
Stockholders Equity | -1.91B | -1.39B | -1.37B | -1.37B | -1.63B |
Cash Flow | |||||
Free Cash Flow | 120.00M | -257.00M | -124.00M | -603.00M | 1.74B |
Operating Cash Flow | 480.00M | 210.00M | 300.00M | -131.00M | 2.18B |
Investing Cash Flow | -275.00M | -26.00M | -259.00M | -524.00M | 177.00M |
Financing Cash Flow | -206.00M | -264.00M | -430.00M | -514.00M | -895.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | $1.12B | 109.33 | 2.28% | ― | 5.17% | -65.33% | |
56 Neutral | $779.90M | 18.62 | -40.13% | ― | -14.33% | -398.68% | |
53 Neutral | $402.48M | ― | -21.72% | ― | -0.39% | -1408.40% | |
51 Neutral | $7.83B | -0.18 | -40.10% | 2.29% | 21.46% | -2.03% | |
51 Neutral | $381.12M | ― | 39.18% | ― | 0.80% | -95.01% | |
47 Neutral | $523.85M | ― | -12.03% | ― | 12.19% | -1.59% | |
45 Neutral | $433.44M | ― | -1.96% | ― | -24.30% | -210.27% |
On August 12, 2025, Community Health Systems, Inc. completed its offering of $1.79 billion in 9.750% Senior Secured Notes due 2034, which are guaranteed by the company and its subsidiaries. The proceeds from this offering, along with cash on hand, were used to repurchase a significant portion of its outstanding 5.625% Senior Secured Notes due 2027, with plans to refinance the remaining balance. This strategic financial maneuver aims to optimize the company’s debt structure and improve its financial flexibility.
On July 28, 2025, Community Health Systems, Inc. announced that its subsidiary priced an offering of $1,790 million in Senior Secured Notes due 2034, an increase from the initially proposed $1,500 million. The proceeds will be used to refinance existing notes due in 2027. Additionally, the company launched a cash tender offer for its 2027 Notes, increasing the offer size by $287 million. This financial maneuver aims to strengthen the company’s financial position by managing its debt obligations more effectively.
Community Health Systems, Inc. reported its financial results for the second quarter ending June 30, 2025, showing a significant turnaround with a net income of $282 million compared to a net loss in the same period of 2024. The company completed significant financial transactions, including the offering of $700 million in senior secured notes and the redemption of existing notes, which resulted in a net pre-tax gain from early debt extinguishment. Additionally, the company divested several hospital interests and entered into an agreement with Labcorp to sell select assets of its ambulatory outreach laboratory services for $195 million. These actions reflect the company’s strategic initiatives to strengthen its financial position and focus on core operations.
On July 23, 2025, Community Health Systems announced the retirement of Tim L. Hingtgen as CEO and board member, effective September 30, 2025. Hingtgen’s departure is amicable, and he will continue to advise the company as a consultant. Kevin J. Hammons, currently President and CFO, will become Interim CEO, and Jason K. Johnson will step in as Interim CFO. These leadership changes are expected to ensure a seamless transition and continued focus on enhancing patient care and company performance.
On July 22, 2025, Community Health Systems, Inc. announced a definitive agreement to sell select assets of its ambulatory outreach laboratory services to Labcorp for $195 million. This transaction, expected to close in the fourth quarter of 2025, aims to enhance patient and provider access to Labcorp’s comprehensive testing services while allowing CHS to focus on its core healthcare services. The agreement includes a non-competition clause and plans for a smooth transition to maintain service continuity.
On June 30, 2025, Community Health Systems, Inc. completed the sale of its 80% ownership interest in the Cedar Park Health System joint venture to Ascension Health for $436 million in cash. This transaction, which was initially agreed upon in April 2025, marks a significant disposition for CHS, potentially impacting its financial structure and market positioning.